Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

Steven Piantadosi, GB Vogelsang, ER Farmer, +5

Blood

Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial

JE Wagner, GW Santos, SJ Noga, +7

Blood

Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow

DS Bross, PJ Tutschka, ER Farmer, +5

Blood

Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow

DS Bross, PJ Tutschka, ER Farmer, +5

Blood

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]

AM Yeager, Vogelsang Gb, RJ Jones, +4

Blood

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.

Georgia B. Vogelsang, Roy Beveridge, ER Farmer, +3

Journal of Clinical Oncology

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia [see comments]

AM Yeager, GB Vogelsang, RJ Jones, +4

Blood

Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial

Wagner Je, GW Santos, SJ Noga, +7

Blood

Predictors of death from chronic graft-versus-host disease after bone marrow transplantation

Steven Piantadosi, GB Vogelsang, ER Farmer, +5

Blood